KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Cash & Equivalents (2017 - 2025)

Arcosa's Cash & Equivalents history spans 9 years, with the latest figure at $214.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 14.58% year-over-year to $214.6 million; the TTM value through Dec 2025 reached $214.6 million, up 14.58%, while the annual FY2025 figure was $214.6 million, 14.58% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $214.6 million at Arcosa, down from $220.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $756.8 million in Q3 2024 and bottomed at $66.1 million in Q3 2021.
  • The 5-year median for Cash & Equivalents is $152.2 million (2023), against an average of $169.2 million.
  • The largest annual shift saw Cash & Equivalents surged 387.31% in 2024 before it crashed 70.93% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $72.9 million in 2021, then soared by 120.03% to $160.4 million in 2022, then plummeted by 34.66% to $104.8 million in 2023, then surged by 78.72% to $187.3 million in 2024, then rose by 14.58% to $214.6 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's Cash & Equivalents are $214.6 million (Q4 2025), $220.0 million (Q3 2025), and $189.7 million (Q2 2025).